Roche Maintains Stability Amid Share Price Decline
Roche's business remains robust with no job cuts planned despite a dip in share prices. The company maintains a stable R&D budget, signaling continued growth.
Topic
Roche
A collection of 6 issues
Roche CEO Highlights U.S. Growth, China Challenges, European Recovery
Roche CEO discusses U.S. economic growth, addressing China's market challenges, and observing a slow economic recovery in Europe. Discover insights now.
Roche Maintains Steady R&D Budget
Roche's research and development budget remains unchanged, signaling a stable commitment to innovation. Explore the implications for the pharmaceutical giant's future.
Roche's Anti-Obesity Drug May Launch by 2029
Roche is developing a promising anti-obesity drug, potentially hitting the market by 2029. Stay updated on this exciting advancement in weight management solutions.
Roche Maintains Steady Workforce Amid Economic Uncertainty
Roche's workforce remains steady with slight growth, signaling stability and no imminent layoffs. Explore the implications for the biotech giant's future.
Roche Shares Tumble from April 2022 Peaks
Roche's share price has significantly declined since its April 2022 highs. Explore the factors impacting Roche's stock performance today.